A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib"
- PMID: 39242150
- DOI: 10.1016/j.jtho.2024.07.001
A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib"
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical